Drug
MT 401 Ots
MT 401 Ots: highest development phase Phase 1, developed by Marker Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Marker Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| MT-401-OTS NCT06552416 | Phase 1 | Acute Myeloid Leukemia, in Relapse |
Latest
No recent events.
Follow MT 401 Ots on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.